Atlas Trials

A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD)

Clinical trial NCT02986724 · COMPLETED

Trial details

NCT number
NCT02986724
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Crohn DiseaseColitis, UlcerativeInflammatory Bowel Diseases
Start date
2017-01-04
Primary completion
2020-08-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.